Herbas VPB

Print
EN | LT
Supplementary protection
LT - Antigeną surišantys baltymai prieš subtilizino/keksino tipo 9 proproteino konvertazę (PCSK9)
EN - ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
SPC
(11) Number of the document C 2215124
(68) Number of the document 2215124
(21) Application number for Supplementary Protection Certificate PA 2016 021
(22) Date of filing the application 2016-06-02
(41) Date of publication of the application 2016-06-27
Date of publication of SPC 2021-04-12
(24) Date of coming into effect of SPC 2028-08-23
Applicant
(71) Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Grantee
(73) Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU1/15/1016, 2015-07-17
Calculated date of expiry of the SPC
(94) 2030-07-21
Name of the product protected by the basic patent
(95) Evolocumabum
Paediatric extension
Request filed SPC extension granted until Request refused
2023-03-23 2031-01-21
Legal status
SPC term extension granted
Last update date 2023-04-24